On December 23, 2020, the 3rd Guangdong-Hong Kong-Macao Greater Bay Area Top 50 Biotechnology Innovative Enterprises Award Ceremony was held in Nansha, Guangzhou. More than 400 representatives from the government, investment institutions, biotechnology companies, scientific research institutions and media representatives Witnessed together, the conference solemnly released the '3rd Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Innovative Enterprises Top 50 List'. Respley was on the list and won the 3rd Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Innovative Enterprises Top 50 Pioneer enterprise. 

Figure 1-Figure 2 Honor certificate and honor trophy 

The selection activity was officially launched in July 2020 and lasted for 4 months. The selection scope covers three areas of medical devices, biomedicine and technology, and medical services. It comprehensively evaluates participants from the three dimensions of innovative technology, market application, and capital. To select the technological innovation and future development prospects of enterprises, a panel of judges and experts from government agencies, third-party research, professional investment, and medical institutions will select the list of authoritative innovative enterprises after in-depth investigations of the enterprises. In this year's top 50 list, there are 23 biomedical companies and 15 medical device companies, including Nasdaq-listed companies such as Burning Rock Medical and Genetron Health. 

Figure 3 The awarding scene 

Figure 4 Dr. Chen Yongqi as the award-winning representative of Pioneer Enterprises

KPMG China South China Biotechnology Tax Lead Partner said, “The 50 Greater Bay Area biotechnology innovation companies on the list this year come from the fields of medical devices, biopharmaceuticals, and medical services. Their performance in all aspects is very impressive, and they have taken a step forward. The strength to develop into the backbone of the biotechnology industry in the Greater Bay Area. In the future, the Greater Bay Area will continue to introduce high-quality capital relying on the cluster effect and policy dividends to escort the development of biotech companies in the region.' 

Figure 5 List of pioneer companies 

 Resproly is strongly supported by Zhuhai Municipal Government, Zhuhai Science and Technology Innovation Bureau, and Zhuhai Jinwan District Government.